SUCCESSFUL TRANSFUSION OF PLATELETS MISMATCHED FOR HLA ANTIGENS TO ALLOIMMUNIZED THROMBOCYTOPENIC PATIENTS

被引：179
|
作者：
DUQUESNOY, RJ
FILIP, DJ
RODEY, GE
RIMM, AA
ASTER, RH
机构：
[1] MILWAUKEE BLOOD CTR INC,MILWAUKEE,WI 53201
[2] MED COLL WISCONSIN,DEPT MICROBIOL,MILWAUKEE,WI 53233
[3] MED COLL WISCONSIN,DEPT MED,MILWAUKEE,WI 53233
[4] MED COLL WISCONSIN,DEPT PATHOL,MILWAUKEE,WI 53233
[5] MED COLL WISCONSIN,DEPT BIOSTAT,MILWAUKEE,WI 53233
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 1977年 / 2卷 / 03期
关键词：
D O I：
10.1002/ajh.2830020303
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：219 / 226
页数：8
相关论文
共 50 条
  • [21] Successful treatment of platelet transfusion refractoriness. The use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized leukaemia patients
    Kekomaki, S
    Volin, L
    Koistinen, P
    Koivunen, E
    Timonen, T
    Kekomaki, R
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS315 - PS315
  • [22] HLA matchmaker: A molecularly based platelet donor selection strategy for highly HLA alloimmunized thrombocytopenic patients.
    Duquesnoy, RJ
    Steer, K
    Lopez-Plaza, I
    TRANSFUSION, 1999, 39 (10) : 98S - 98S
  • [23] INDEPENDENT ROLES FOR PLATELET CROSS-MATCHING AND HLA IN THE SELECTION OF PLATELETS FOR ALLOIMMUNIZED PATIENTS
    FRIEDBERG, RC
    DONNELLY, SF
    MINTZ, PD
    TRANSFUSION, 1994, 34 (03) : 215 - 220
  • [24] A COST-EFFECTIVENESS EVALUATION OF PLATELET CROSSMATCHING AND HLA MATCHING IN THE MANAGEMENT OF ALLOIMMUNIZED THROMBOCYTOPENIC PATIENTS
    FREEDMAN, J
    GAFNI, A
    GARVEY, MB
    BLANCHETTE, V
    TRANSFUSION, 1989, 29 (03) : 201 - 207
  • [25] CLINICAL USEFULNESS OF HLA-ANTIBODY ANALYSIS OF ALLOIMMUNIZED THROMBOCYTOPENIC PATIENTS REQUIRING PLATELET TRANSFUSIONS
    MARRARI, M
    ORAL, A
    DUQUESNOY, RJ
    HUMAN IMMUNOLOGY, 1986, 17 (02) : 203 - 204
  • [26] SUCCESSFUL TREATMENT OF MISMATCHED BLOOD TRANSFUSION
    VARNEY, JH
    COKER, JK
    CAWLEY, JJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1951, 145 (13): : 978 - 978
  • [27] The reduction of HLA class I expression on platelets: A potential approach in the management of HLA-alloimmunized refractory patients
    Novotny, VMJ
    Doxiadis, IIN
    Brand, A
    TRANSFUSION MEDICINE REVIEWS, 1999, 13 (02) : 95 - 105
  • [28] Provision of HLA mismatched platelets for immunologically refractory patients using an HLA non-immunogenic epitope mismatched strategy
    Papassavas, AC
    Brown, C
    Brough, S
    Ouwehand, WH
    Navarrete, CV
    GENES AND IMMUNITY, 2003, 4 : S7 - S7
  • [29] The effectiveness of an antibody specificity prediction (ASP) method for selecting platelets for transfusion to alloimmunized patients.
    Petz, LD
    Garratty, G
    Clark, BD
    Cecka, M
    Calhoun, L
    Gresens, C
    Smith, R
    Kleinman, S
    Lill, M
    Terasaki, P
    BLOOD, 1995, 86 (10) : 2171 - 2171
  • [30] Complement Inhibition Using Eculizumab Overcomes Platelet Transfusion Refractoriness in Allo-Immunized Patients Receiving HLA Mismatched Platelets
    Vo, Phuong T.
    Purev, Enkhtsetseg
    West, Kamille A.
    Hochman, Michael
    McDuffee, Emily C.
    Worthy, Tatyana
    Cook, Lisa
    Ramos, Catalina
    Wells, Brian
    Flegel, Willy A.
    Adams, Sharon
    Reger, Robert N.
    Aue, Georg
    Childs, Richard W.
    BLOOD, 2016, 128 (22)
12345